Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 42 EP applications Evangelia Ttofi has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 27, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12722820

PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN CALCIUM

IPC classification:
A61K 31/505, A61K 9/50, A61K 9/20, A61K 9/16
Applicant:
AstraZeneca UK Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Agent:
Anne Rachel Burton Williams, AstraZeneca PLC
Status:
The patent has been granted
EP11799104

ANTI-IL-18 ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/24
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11769881

THERAPIES FOR IMPROVING PULMONARY FUNCTION

IPC classification:
A61K 39/395, A61P 37/08, G01N 33/577, C07K 16/24
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
The patent has been granted
EP12196199

Antibodies with decreased deamidation profiles

IPC classification:
A61K 47/26, A61K 47/18, A61K 47/12, A61K 47/02, A61K 39/395, A61K 9/00, C07K 16/24
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13168817

Methods of treating systemic lupus erythematosus

IPC classification:
A61K 39/395, C07K 16/24, C07K 16/00
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11842005

REGIMENS FOR TREATMENTS USING ANTI-IGF ANTIBODIES

IPC classification:
C12P 21/08, A61K 39/00, C07K 16/22, A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12830128

METHODS FOR PROCESSING COAGULATION FACTORS

IPC classification:
C12P 21/02
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP12770487

TREATMENT FOR RHEUMATOID ARTHRITIS

IPC classification:
C07K 16/28, A61P 19/02
Applicant:
MedImmune Limited
Agent:
Carpmaels & Ransford LLP
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP12847479

COMBINATION THERAPIES USING ANTI- PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

IPC classification:
A61K 39/395, A61K 39/00, C12P 21/08, C07K 16/00
Applicant:
MedImmune Limited
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP12848121

MULTISPECIFIC AND MULTIVALENT BINDING PROTEINS AND USES THEREOF

IPC classification:
A61K 39/00
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP12789521

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS, SCLERODERMA, AND MYOSITIS WITH AN ANTIBODY AGAINST INTERFERON-ALPHA

IPC classification:
A61K 39/395, A61K 39/00, C07K 16/42, C07K 16/28
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12785244

METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS

IPC classification:
G06F 19/00, G01N 33/569
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP12807214

METHODS FOR MAKING MULTIMERIC POLYPEPTIDES

IPC classification:
C07K 16/46, C07K 16/28, C07K 16/00, C07K 14/00
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11813105

METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCOJUGATES

IPC classification:
B01J 41/14, C07K 1/18, A61K 47/48, C07K 16/28, B01J 41/20, B01D 15/04
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
The patent has been granted
EP13772497

DEVICES HAVING THERMOCHROMIC RESPONSE INDICATORS

IPC classification:
A61M 5/50, A61J 1/18
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11835117

METHODS FOR PROCESSING INCLUSION BODIES

IPC classification:
C07K 1/34, C07K 1/113
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP13770070

TRANSMUCOSAL DELIVERY OF ENGINEERED POLYPEPTIDES

IPC classification:
A61K 38/17, A61K 38/16, A61P 17/00
Applicant:
AstraZeneca Pharmaceuticals LP
Agent:
Charlotte Teall, Forresters IP LLP
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14191479

Disease markers and uses thereof

IPC classification:
C12Q 1/68
Applicant:
The Brigham and Women's Hospital, Inc.
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13703012

PROCESS FOR REDUCING ANTIBODY AGGREGATE LEVELS AND ANTIBODIES PRODUCED THEREBY

IPC classification:
C07K 16/18
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP13803921

FIXED DOSAGE REGIMENS FOR ANTI-TYPE I INTERFERON RECEPTOR (IFNAR) ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/24, C07K 16/00
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP13787673

CTLA-4 VARIANTS

IPC classification:
A61K 38/16, C07K 1/00
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP13848584

STABLE, LOW VISCOSITY ANTIBODY FORMULATION

IPC classification:
A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Graham Matthew Lewis, J A Kemp
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP13854850

SWINE INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

IPC classification:
A61K 39/145
Applicant:
MedImmune, LLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13853844

METHODS OF TREATING S. AUREUS-ASSOCIATED DISEASES

IPC classification:
A61K 39/085
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14776495

RECOMBINANT POLYPEPTIDE PRODUCTION

IPC classification:
C12N 5/16, C12N 5/07, C12P 21/06, C12P 19/34
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP14709713

PEGYLATED GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF OBESITY

IPC classification:
C07K 14/605, A61K 47/48
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14797310

PURIFICATION OF RECOMBINANTLY PRODUCED POLYPEPTIDES

IPC classification:
C07K 1/22
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15176691

PANCREATIC POLYPEPTIDE FAMILY MOTIFS, POLYPEPTIDES AND METHODS COMPRISING THE SAME

IPC classification:
A61K 38/17, C07K 14/435
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Agent:
Charlotte Teall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14835826

METHODS FOR REDUCING EXACERBATION RATES OF ASTHMA USING BENRALIZUMAB

IPC classification:
G01N 33/48, A61K 39/395, A61K 39/00
Applicant:
AstraZeneca AB
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14752848

GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETES

IPC classification:
C12N 15/62, C07K 14/575, C07K 14/605
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14761317

COMPOSITIONS FEATURING AN ATTENUATED NEWCASTLE DISEASE VIRUS AND METHODS OF USE FOR TREATING NEOPLASIA

IPC classification:
C12N 15/86, C07K 14/535, A61K 35/76
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP14777632

METHODS OF TREATING AND DIAGNOSING ALPHA-V-BETA-6 OVEREXPRESSING CANCER

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/32, C07K 16/28
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14853201

METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING BENRALIZUMAB

IPC classification:
G01N 33/48, A61K 39/00
Applicant:
AstraZeneca AB
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14855343

STABLE, AQUEOUS ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395, A61K 38/00
Applicant:
AstraZeneca AB
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP15190653

METHODS OF REDUCING BASOPHIL LEVELS

IPC classification:
C07K 16/28, A61K 39/395
Applicant:
AstraZeneca AB
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
The patent has been granted
EP14870799

COMPOSITIONS AND METHODS FOR TREATING SARCOMA

IPC classification:
A61P 35/00, A61K 39/395
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15752581

ANTI-PCSK9~GLP-1 FUSIONS AND METHODS FOR USE

IPC classification:
A61P 3/10, A61K 38/26, C07K 16/46, C07K 16/40
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15799339

OX40L FUSION PROTEINS AND USES THEREOF

IPC classification:
C12P 21/08, A61K 39/00
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15832244

DETECTING RESIDUAL HOST CELL PROTEINS IN RECOMBINANT PROTEIN PREPARATIONS

IPC classification:
C40B 30/04
Agent:
AstraZeneca PLC
Agent:
Evangelia Ttofi, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15777638

COMBINATION OF AN OMEGA-3 FATTY ACID AND AN SGLT-2 INHIBITOR FOR TREATING DISEASES OF THE LIVER

IPC classification:
A61K 31/7034, A61K 31/202, A61K 45/06, A61P 3/10, A61P 3/04, A61P 1/16
Applicant:
AstraZeneca AB
Agent:
Evangelia Ttofi, MedImmune Limited
Agent:
AstraZeneca PLC
Status:
Request for examination was made
EP15775130

1-ALKYL-6-OXO-1,6-DIHYDROPYRIDIN-3-YL COMPOUNDS AND USE AS SGRM MODULATORS

IPC classification:
A61P 19/02, A61K 31/4439, C07D 401/04
Applicant:
AstraZeneca AB
Agent:
Evangelia Ttofi, MedImmune Limited
Agent:
AstraZeneca PLC
Status:
Request for examination was made
EP15784930

BINDING PROTEINS SPECIFIC FOR LOX1 AND USES THEREOF

IPC classification:
C12N 15/113, C07K 16/28
Applicant:
MedImmune Limited
Agent:
Evangelia Ttofi, MedImmune Limited
Agent:
AstraZeneca PLC
Status:
Request for examination was made

Please Sign in to use this feature